Supplier profile
Pfizer Pharma GmbH
Every public-sector award we hold for this supplier, across Germany, from 29 Jun 2010 to 23 Sept 2026.
Awards won
141
all time
Attributed value
€228k
104 shared, unvalued
Buyers
36
public bodies
Active
2010–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| GWQ ServicePlus AG | 20 | €1 |
| DAK-Gesundheit | 17 | not attributable |
| IKK classic | 17 | €59k |
| Techniker Krankenkasse | 13 | not attributable |
| AOK Baden-Württemberg | 11 | not attributable |
| AOK Nordost – Die Gesundheitskasse | 7 | not attributable |
| Deutsche Rentenversicherung Knappschaft-Bahn-See | 5 | not attributable |
| spectrumK GmbH | 5 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 4 | not attributable |
| AOK Sachsen - Anhalt | 4 | €2 |
What they win
Awards
Showing 26–50 of 141 awards we hold
- Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu Palbociclib (Ibrance) ↗GWQ ServicePlus AG€1awarded 4 Jul 2025
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Palbociclib ↗AOK Sachsen - Anhaltawarded 2 Jul 2025
- Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Palbociclib ↗AOK Sachsen - Anhaltawarded 1 Jul 2025
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Pfizer Pharma GmbH zu Ibrance(R) ↗IKK classic€1awarded 2 May 2025
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Pfizer Pharma GmbH zu Ibrance(R) ↗IKK classic€1awarded 30 Apr 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Filgrastim, ATC L03AA02 für die Zeit 01.04.2024 - 31.03.2026 ↗DAK-Gesundheitshared awardawarded 2 Apr 2025
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 ↗PBMG eGawarded 10 Mar 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Mar 2025
- Germany – Vaccines – RV Lieferung RSV-lmpfstoff (Respiratorischen Synzytial-Virus) ab 60 Jahren ↗Landesamt für innere Verwaltung M-V, Abteilung Beschaffung/Dienstleistungenawarded 20 Feb 2025
- RV Lieferung RSV-lmpfstoff (Respiratorischen Synzytial-Virus) ab 60 Jahren ↗Landesamt für innere Verwaltung M-V, Abteilung Beschaffung/Dienstleistungen€169kawarded 20 Feb 2025
- ENGERIX B ERWACHSENE FSP N1 ↗Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehrawarded 15 Jan 2025
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8a und 130c Abs. 1 SGB V zwischen der IKK classic und der Pfizer GmbH zu Hympavzi ↗IKK classic€1awarded 10 Jan 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin zeta), ATC B03XA01 für die Zeit 01.12.2024 - 30.11.2026 ↗DAK-Gesundheitshared awardawarded 1 Dec 2024
- Vereinbarung gemäß § 130c SGB V zu dem Arzneimittel Cibinqo® mit dem Wirkstoff Abrocitinib ↗AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringenawarded 6 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Minoxidil, ATC C02DC01 für die Zeit 01.11.2024 - 31.10.2026 ↗DAK-Gesundheitshared awardawarded 1 Nov 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Minoxidil, ATC C02DC01 für die Zeit 01.11.2024 - 31.10.2026 ↗DAK-Gesundheitshared awardawarded 1 Nov 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 31 Jul 2024
- Germany – Pharmaceutical products – post_Arzneimittelausschreibung_2024 a ↗IKK classicshared awardawarded 27 Jul 2024
- 001 | Acetylsalicylsäure Tabletten magensaftresistent u.w. [3] [H] ↗IKK classicshared awardawarded 26 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (2;3er) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (1b) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Levetiracetam (FTA) ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 12 Jun 2024
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 1.Juli 2024 ↗PBMG eGawarded 14 May 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.